TY - JOUR AU - Hanahan, D. PY - 2014 DA - 2014// TI - Rethinking the war on cancer JO - Lancet VL - 383 UR - https://doi.org/10.1016/S0140-6736(13)62226-6 DO - 10.1016/S0140-6736(13)62226-6 ID - Hanahan2014 ER - TY - JOUR AU - Northcott, P. A. AU - Pfister, S. M. AU - Jones, D. T. W. PY - 2015 DA - 2015// TI - Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapies JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(14)71206-9 DO - 10.1016/S1470-2045(14)71206-9 ID - Northcott2015 ER - TY - JOUR AU - Wan, P. T. C. AU - Garnett, M. J. AU - Roe, S. M. AU - Lee, S. AU - Niculescu-Duvaz, D. AU - Good, V. M. PY - 2004 DA - 2004// TI - Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF JO - Cell VL - 116 UR - https://doi.org/10.1016/S0092-8674(04)00215-6 DO - 10.1016/S0092-8674(04)00215-6 ID - Wan2004 ER - TY - JOUR AU - Davies, H. AU - Bignell, G. R. AU - Cox, C. AU - Stephens, P. AU - Edkins, S. AU - Clegg, S. PY - 2002 DA - 2002// TI - Mutations of the BRAF gene in human cancer JO - Nature VL - 417 UR - https://doi.org/10.1038/nature00766 DO - 10.1038/nature00766 ID - Davies2002 ER - TY - JOUR AU - Wong, D. J. AU - Ribas, A. PY - 2016 DA - 2016// TI - Targeted Therapy for Melanoma JO - Caner Treat Res VL - 167 UR - https://doi.org/10.1007/978-3-319-22539-5_10 DO - 10.1007/978-3-319-22539-5_10 ID - Wong2016 ER - TY - JOUR AU - Capper, D. AU - Preusser, M. AU - Habel, A. AU - Sahm, F. AU - Ackermann, U. AU - Schindler, G. PY - 2011 DA - 2011// TI - Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody JO - Acta Neuropathol VL - 122 UR - https://doi.org/10.1007/s00401-011-0841-z DO - 10.1007/s00401-011-0841-z ID - Capper2011 ER - TY - JOUR AU - Colomba, E. AU - Helias-Rodzewicz, Z. AU - Deimling, A. AU - Marin, C. AU - Terrones, N. AU - Pechaud, D. PY - 2013 DA - 2013// TI - Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing JO - J Mol Diagn VL - 15 UR - https://doi.org/10.1016/j.jmoldx.2012.09.001 DO - 10.1016/j.jmoldx.2012.09.001 ID - Colomba2013 ER - TY - JOUR AU - Dvorak, K. AU - Aggeler, B. AU - Palting, J. AU - McKelvie, P. AU - Ruszkiewicz, A. AU - Waring, P. PY - 2014 DA - 2014// TI - Immunohitochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma JO - Pathology VL - 46 UR - https://doi.org/10.1097/PAT.0000000000000119 DO - 10.1097/PAT.0000000000000119 ID - Dvorak2014 ER - TY - JOUR AU - Ilie, M. AU - Long, E. AU - Hofman, V. AU - Dadone, B. AU - Marquette, C. H. AU - Mouroux, J. PY - 2013 DA - 2013// TI - Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mds534 DO - 10.1093/annonc/mds534 ID - Ilie2013 ER - TY - JOUR AU - Ida, C. M. AU - Vrana, J. A. AU - Rodriguez, F. J. AU - Jentoft, M. E. AU - Caron, A. A. AU - Jenkins, S. M. PY - 2013 DA - 2013// TI - Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytomas JO - Acta Neuropathol Commun VL - 1 UR - https://doi.org/10.1186/2051-5960-1-20 DO - 10.1186/2051-5960-1-20 ID - Ida2013 ER - TY - JOUR AU - Ritterhouse, L. L. AU - Barletta, J. A. PY - 2015 DA - 2015// TI - BRAF V600E mutation-specific antibody: A review JO - Semin Diagn Pathol VL - 32 UR - https://doi.org/10.1053/j.semdp.2015.02.010 DO - 10.1053/j.semdp.2015.02.010 ID - Ritterhouse2015 ER - TY - JOUR AU - Brandner, S. AU - Deimling, A. PY - 2015 DA - 2015// TI - Diagnostic, prognostic and predictive relevance of molecular markers in gliomas JO - Neuropahol Appl Neurobiol VL - 41 UR - https://doi.org/10.1111/nan.12246 DO - 10.1111/nan.12246 ID - Brandner2015 ER - TY - JOUR AU - Capper, D. AU - Berghoff, A. S. AU - Magerle, M. AU - Ilhan, A. AU - Wöhrer, A. AU - Hackl, M. PY - 2012 DA - 2012// TI - Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases JO - Acta Neuropathol VL - 123 UR - https://doi.org/10.1007/s00401-011-0887-y DO - 10.1007/s00401-011-0887-y ID - Capper2012 ER - TY - JOUR AU - Cardarella, S. AU - Ogino, A. AU - Nishino, M. AU - Butaney, M. AU - Shen, J. AU - Lydon, C. PY - 2013 DA - 2013// TI - Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-13-0657 DO - 10.1158/1078-0432.CCR-13-0657 ID - Cardarella2013 ER - TY - JOUR AU - Villalva, C. AU - Duranton-Tanneur, V. AU - Guilloteau, K. AU - Burel-Vandenbos, F. AU - Wager, M. AU - Doyen, J. PY - 2013 DA - 2013// TI - EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients JO - Cancer Med VL - 2 UR - https://doi.org/10.1002/cam4.82 DO - 10.1002/cam4.82 ID - Villalva2013 ER - TY - JOUR AU - Barras, D. PY - 2015 DA - 2015// TI - BRAF Mutation in Colorectal Cancer: An Update JO - Biomarkers Cancer VL - 7 UR - https://doi.org/10.4137/BIC.S25248 DO - 10.4137/BIC.S25248 ID - Barras2015 ER - TY - JOUR AU - Kimura, E. T. AU - Nikiforova, M. N. AU - Zhu, Z. AU - Knauf, J. A. AU - Nikiforov, Y. E. AU - Fagin, J. A. PY - 2003 DA - 2003// TI - High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma JO - Cancer Res VL - 63 ID - Kimura2003 ER - TY - JOUR AU - Xing, M. PY - 2005 DA - 2005// TI - BRAF mutation in thyroid cancer JO - Endocr RelatCancer VL - 12 ID - Xing2005 ER - TY - JOUR AU - Elisei, R. AU - Viola, D. AU - Torregrossa, L. AU - Giannini, R. AU - Romei, C. AU - Ugolini, C. PY - 2012 DA - 2012// TI - The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study JO - J Clin Endocrinol Metab VL - 97 UR - https://doi.org/10.1210/jc.2012-1775 DO - 10.1210/jc.2012-1775 ID - Elisei2012 ER - TY - JOUR AU - Jones, D. T. W. AU - Kocialkowski, S. AU - Liu, L. AU - Pearson, D. M. AU - Bäcklund, L. M. AU - Ichimura, K. PY - 2008 DA - 2008// TI - Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-2097 DO - 10.1158/0008-5472.CAN-08-2097 ID - Jones2008 ER - TY - JOUR AU - Schindler, G. AU - Capper, D. AU - Meyer, J. AU - Janzarik, W. AU - Omran, H. AU - Herold-Mende, C. PY - 2011 DA - 2011// TI - Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma JO - Acta Neuropathol VL - 121 UR - https://doi.org/10.1007/s00401-011-0802-6 DO - 10.1007/s00401-011-0802-6 ID - Schindler2011 ER - TY - JOUR AU - Tabouret, E. AU - Bequet, C. AU - Denicolaï, E. AU - Barrié, M. AU - Nanni, I. AU - Metellus, P. PY - 2015 DA - 2015// TI - BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma JO - Eur J Surg Oncol VL - 41 UR - https://doi.org/10.1016/j.ejso.2015.09.012 DO - 10.1016/j.ejso.2015.09.012 ID - Tabouret2015 ER - TY - JOUR AU - Dahiya, S. AU - Haydon, D. H. AU - Alvarado, D. AU - Gurnett, C. A. AU - Gutmann, D. H. AU - Leonard, J. R. PY - 2013 DA - 2013// TI - BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma JO - Acta Neuropathol VL - 125 UR - https://doi.org/10.1007/s00401-013-1120-y DO - 10.1007/s00401-013-1120-y ID - Dahiya2013 ER - TY - JOUR AU - Ho, C. Y. AU - Mobley, B. C. AU - Gordish-Dressman, H. AU - VandenBussche, C. J. AU - Mason, G. E. AU - Bornhorst, M. PY - 2015 DA - 2015// TI - A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation JO - Acta Neuropathol VL - 130 UR - https://doi.org/10.1007/s00401-015-1467-3 DO - 10.1007/s00401-015-1467-3 ID - Ho2015 ER - TY - JOUR AU - Zhang, J. AU - Wu, G. AU - Miller, C. P. AU - Tatevossian, R. G. AU - Dalton, J. D. AU - Tang, B. PY - 2013 DA - 2013// TI - Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas JO - Nat Genet VL - 45 UR - https://doi.org/10.1038/ng.2611 DO - 10.1038/ng.2611 ID - Zhang2013 ER - TY - JOUR AU - Roth, J. J. AU - Santi, M. AU - Rorke-Adams, L. B. AU - Harding, B. N. AU - Busse, T. M. AU - Tooke, L. S. PY - 2014 DA - 2014// TI - Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors JO - Cancer Genet VL - 207 UR - https://doi.org/10.1016/j.cancergen.2014.03.002 DO - 10.1016/j.cancergen.2014.03.002 ID - Roth2014 ER - TY - JOUR AU - Ramkissoon, L. A. AU - Horowitz, P. M. AU - Craig, J. M. AU - Ramkissoon, S. H. AU - Rich, B. E. AU - Schumacher, S. E. PY - 2013 DA - 2013// TI - Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1 JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1300252110 DO - 10.1073/pnas.1300252110 ID - Ramkissoon2013 ER - TY - JOUR AU - Cruz, G. R. AU - Dias Oliveira, I. AU - Moraes, L. AU - Giudice, P. M. AU - Seixas Alves, M. T. AU - Capellano, A. M. PY - 2014 DA - 2014// TI - Analysis of KIAA1549-BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas JO - J Neuro-Oncol VL - 117 UR - https://doi.org/10.1007/s11060-014-1398-1 DO - 10.1007/s11060-014-1398-1 ID - Cruz2014 ER - TY - JOUR AU - Gierke, M. AU - Sperveslage, J. AU - Schwab, D. AU - Beschorner, R. AU - Ebinger, M. AU - Schuhmann, M. U. PY - 2016 DA - 2016// TI - Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification JO - J Cancer Res Clin Oncol VL - 142 UR - https://doi.org/10.1007/s00432-015-2006-2 DO - 10.1007/s00432-015-2006-2 ID - Gierke2016 ER - TY - JOUR AU - Rush, S. AU - Foreman, N. AU - Liu, A. PY - 2013 DA - 2013// TI - Brainstem ganglioglioma successfully treated with vemurafenib JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.44.1568 DO - 10.1200/JCO.2012.44.1568 ID - Rush2013 ER - TY - JOUR AU - Bautista, F. AU - Paci, A. AU - Minard-Colin, V. AU - Dufour, C. AU - Grill, J. AU - Lacroix, L. PY - 2014 DA - 2014// TI - Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas JO - Pediatr Blood Cancer VL - 61 UR - https://doi.org/10.1002/pbc.24891 DO - 10.1002/pbc.24891 ID - Bautista2014 ER - TY - JOUR AU - Chamberlain, M. C. PY - 2013 DA - 2013// TI - Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series JO - J Neuro-Oncol VL - 114 UR - https://doi.org/10.1007/s11060-013-1176-5 DO - 10.1007/s11060-013-1176-5 ID - Chamberlain2013 ER - TY - JOUR AU - Usubalieva, A. AU - Pierson, C. R. AU - Kavran, C. A. AU - Huntoon, K. AU - Kryvenko, O. N. AU - Mayer, T. G. PY - 2015 DA - 2015// TI - Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAFV600E Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib JO - J Neuropathol Exp Neurol VL - 74 UR - https://doi.org/10.1097/NEN.0000000000000240 DO - 10.1097/NEN.0000000000000240 ID - Usubalieva2015 ER - TY - JOUR AU - Skrypek, M. AU - Foreman, N. AU - Guillaume, D. AU - Moertel, C. PY - 2014 DA - 2014// TI - Pilomyxoid astrocytoma treated successfully with vemurafenib JO - Pediatr Blood Cancer VL - 61 UR - https://doi.org/10.1002/pbc.25084 DO - 10.1002/pbc.25084 ID - Skrypek2014 ER - TY - JOUR AU - Kleinschmidt-DeMasters, B. K. AU - Aisner, D. L. AU - Birks, D. K. AU - Foreman, N. K. PY - 2013 DA - 2013// TI - Epithelioid GBMs show a high percentage of BRAF V600E mutation JO - Am J Surg Pathol VL - 37 UR - https://doi.org/10.1097/PAS.0b013e31827f9c5e DO - 10.1097/PAS.0b013e31827f9c5e ID - Kleinschmidt-DeMasters2013 ER - TY - JOUR AU - Robinson, G. W. AU - Orr, B. A. AU - Gajjar, A. PY - 2014 DA - 2014// TI - Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-258 DO - 10.1186/1471-2407-14-258 ID - Robinson2014 ER - TY - JOUR AU - Kleinschmidt-DeMasters, B. K. AU - Aisner, D. L. AU - Foreman, N. K. PY - 2015 DA - 2015// TI - BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation JO - Am J Surg Pathol VL - 39 UR - https://doi.org/10.1097/PAS.0000000000000363 DO - 10.1097/PAS.0000000000000363 ID - Kleinschmidt-DeMasters2015 ER - TY - STD TI - Nicolaides TP, Li H, Solomon DA, Hariono S, Hashizume R, Barkovich K, et al. Targeted therapy for BRAFV600E malignant astrocytoma. Clin. Cancer Res. 2011;17(24):7597–604 ID - ref38 ER - TY - JOUR AU - Basto, D. AU - Trovisco, V. AU - Lopes, J. M. AU - Martins, A. AU - Pardal, F. AU - Soares, P. PY - 2005 DA - 2005// TI - Mutation analysis of B-RAF gene in human gliomas JO - Acta Neuropathol VL - 109 UR - https://doi.org/10.1007/s00401-004-0936-x DO - 10.1007/s00401-004-0936-x ID - Basto2005 ER - TY - JOUR AU - Hagemann, C. AU - Gloger, J. AU - Anacker, J. AU - Said, H. M. AU - Gerngras, S. AU - Kühnel, S. PY - 2009 DA - 2009// TI - RAF expression in human astrocytic tumors JO - Int J Mol Med VL - 23 ID - Hagemann2009 ER - TY - JOUR AU - Knobbe, C. B. AU - Reifenberger, J. AU - Reifenberger, G. PY - 2004 DA - 2004// TI - Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas JO - Acta Neuropathol VL - 108 UR - https://doi.org/10.1007/s00401-004-0929-9 DO - 10.1007/s00401-004-0929-9 ID - Knobbe2004 ER - TY - JOUR AU - Saito, A. AU - Nakazato, Y. AU - Yoshii, Y. AU - Hyodo, A. AU - Harakuni, T. AU - Toita, T. PY - 2001 DA - 2001// TI - Anaplastic meningioma with papillary, rhabdoid, and epithelial features: a case report JO - Brain Tumor Pathol VL - 18 UR - https://doi.org/10.1007/BF02479430 DO - 10.1007/BF02479430 ID - Saito2001 ER - TY - JOUR AU - Parameshwaran Nair, R. AU - Vinod Sarma, Y. AU - Nayal, B. AU - Kaur Dil, S. AU - Tripathi, P. K. PY - 2015 DA - 2015// TI - Metastatic rhabdoid meningioma of the parotid - Mimicking primary salivary gland neoplasm JO - Int J Surg Case Rep VL - 6C UR - https://doi.org/10.1016/j.ijscr.2014.10.048 DO - 10.1016/j.ijscr.2014.10.048 ID - Parameshwaran Nair2015 ER - TY - JOUR AU - Mordechai, O. AU - Postovsky, S. AU - Vlodavsky, E. AU - Eran, A. AU - Constantini, S. AU - Dotan, E. PY - 2015 DA - 2015// TI - Metastatic rhabdoid meningioma with BRAF V600E mutation and good response to personalized therapy: case report and review of the literature JO - Pediatr Hematol Oncol VL - 32 UR - https://doi.org/10.3109/08880018.2014.936058 DO - 10.3109/08880018.2014.936058 ID - Mordechai2015 ER - TY - JOUR AU - Sperveslage, J. AU - Gierke, M. AU - Capper, D. AU - Honegger, J. AU - Sipos, B. AU - Beschorner, R. PY - 2013 DA - 2013// TI - VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation JO - Acta Neuropathol VL - 125 UR - https://doi.org/10.1007/s00401-013-1118-5 DO - 10.1007/s00401-013-1118-5 ID - Sperveslage2013 ER - TY - JOUR AU - Roth, A. D. AU - Tejpar, S. AU - Delorenzi, M. AU - Yan, P. AU - Fiocca, R. AU - Klingbiel, D. PY - 2010 DA - 2010// TI - Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.23.3452 DO - 10.1200/JCO.2009.23.3452 ID - Roth2010 ER - TY - JOUR AU - Schafroth, C. AU - Galván, J. A. AU - Centeno, I. AU - Koelzer, V. H. AU - Dawson, H. E. AU - Sokol, L. PY - 2015 DA - 2015// TI - VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer JO - Oncotarget VL - 6 ID - Schafroth2015 ER - TY - JOUR AU - Colombino, M. AU - Sperlongano, P. AU - Izzo, F. AU - Tatangelo, F. AU - Botti, G. AU - Lombardi, A. PY - 2012 DA - 2012// TI - BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy JO - Cell Death Dis VL - 3 UR - https://doi.org/10.1038/cddis.2011.136 DO - 10.1038/cddis.2011.136 ID - Colombino2012 ER - TY - JOUR AU - Llovet, J. M. AU - Ricci, S. AU - Mazzaferro, V. AU - Hilgard, P. AU - Gane, E. AU - Blanc, J. F. PY - 2008 DA - 2008// TI - Sorafenib in advanced hepatocellular carcinoma JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0708857 DO - 10.1056/NEJMoa0708857 ID - Llovet2008 ER - TY - JOUR AU - Vin, H. AU - Ching, G. AU - Ojeda, S. S. AU - Adelmann, C. H. AU - Chitsazzadeh, V. AU - Dwyer, D. W. PY - 2014 DA - 2014// TI - Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK JO - Mol Cancer Ther VL - 13 UR - https://doi.org/10.1158/1535-7163.MCT-13-0561 DO - 10.1158/1535-7163.MCT-13-0561 ID - Vin2014 ER - TY - JOUR AU - Preusser, M. AU - Berghoff, A. S. AU - Capper, D. AU - Deimling, A. AU - Maroske, F. AU - Brodowicz, T. PY - 2013 DA - 2013// TI - No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibody JO - Appl Immunohistochem Mol Morphol VL - 21 UR - https://doi.org/10.1097/PAI.0b013e31827ce693 DO - 10.1097/PAI.0b013e31827ce693 ID - Preusser2013 ER - TY - JOUR AU - Ewing, I. AU - Pedder-Smith, S. AU - Franchi, G. AU - Ruscica, M. AU - Emery, M. AU - Vax, V. PY - 2007 DA - 2007// TI - A mutation and expression analysis of the oncogene BRAF in pituitary adenomas JO - Clin Endocrinol VL - 66 UR - https://doi.org/10.1111/j.1365-2265.2006.02735.x DO - 10.1111/j.1365-2265.2006.02735.x ID - Ewing2007 ER - TY - JOUR AU - Mordes, D. A. AU - Lynch, K. AU - Campbell, S. AU - Dias-Santagata, D. AU - Nose, V. AU - Louis, D. N. PY - 2014 DA - 2014// TI - VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutations JO - Am J Clin Pathol VL - 141 UR - https://doi.org/10.1309/AJCP37TLZLTUAOJL DO - 10.1309/AJCP37TLZLTUAOJL ID - Mordes2014 ER - TY - JOUR AU - Kuan, S. F. AU - Navina, S. AU - Cressman, K. L. AU - Pai, R. K. PY - 2014 DA - 2014// TI - Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization JO - Hum Pathol VL - 45 UR - https://doi.org/10.1016/j.humpath.2013.10.026 DO - 10.1016/j.humpath.2013.10.026 ID - Kuan2014 ER - TY - JOUR AU - Estrella, J. S. AU - Tetzlaff, M. AU - Bassett, R. L. AU - Patel, K. P. AU - Williams, M. D. AU - Curry, J. PY - 2015 DA - 2015// TI - Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-15-0615 DO - 10.1158/1535-7163.MCT-15-0615 ID - Estrella2015 ER -